FDA Inspection 1038343 — HanExpress Logistics Center

HanExpress Logistics Center — FEI 3014034154

The FDA completed an inspection of HanExpress Logistics Center on Aug 9, 2017 in Gyeonggi. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 9, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gyeonggi (Korea (the Republic of))

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.